Company intelligence / Profile preview

BioVinc

Pasadena, California, United Statesbiovinc.com ↗
Ownership
Private
Employees
~7
Development stage
Other
01

Overview

BioVinc is a pre-clinical biotechnology company specializing in the development of bone-targeted therapeutics and diagnostic molecular probes for skeletal diseases and infections. Utilizing its proprietary 'Smart Targeting' platform technology, the company designs skeletal-selective drug conjugates by linking therapeutic agents to bisphosphonates, which have a high affinity for bone minerals. BioVinc's lead pipeline candidate, OsteoFloxacin™ (BV63072), is a bone-targeted sitafloxacin conjugate designed to eradicate biofilms and treat prosthetic joint infections (PJI) and osteomyelitis. Additionally, the company is developing bone-targeted therapies for multiple myeloma and osteonecrosis of the jaw, alongside a commercialized portfolio of fluorescent imaging probes for bone research.

Therapeutic areas
Infectious DiseasesOncology
Modalities
Small moleculeDevice
Industry
Biotech
02

Drug pipeline

3 assets

BVC-210

Preclinical

2 more assets in the full pipeline.

03

Partnerships

PharmaLegacy LabsUS-WorldMeds

Beyond the preview

Go deeper on BioVinc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioVinc.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call